Investor Presentation for NSE and BSE Stocks - Q3FY22

Investor Presentations: Get insights into company performance, financials, capex plans for NSE and BSE stocks - Q3FY22

Quarter
All Jul-Sep 2025 Apr-Jun 2025 Jan-Mar 2025 Oct-Dec 2024 Jul-Sep 2024 Apr-Jun 2024 Jan-Mar 2024 Oct-Dec 2023 Jul-Sep 2023 Apr-Jun 2023 Jan-Mar 2023 Oct-Dec 2022 Jul-Sep 2022 Apr-Jun 2022 Jan-Mar 2022 Oct-Dec 2021 Jul-Sep 2021 Apr-Jun 2021 Jan-Mar 2021 Oct-Dec 2020 Jul-Sep 2020 Apr-Jun 2020 Jan-Mar 2020 Oct-Dec 2019 Jul-Sep 2019 Apr-Jun 2019 Jan-Mar 2019 Oct-Dec 2018 Jul-Sep 2018 Apr-Jun 2018 Jan-Mar 2018 Oct-Dec 2017 Jul-Sep 2017 Apr-Jun 2017 Jan-Mar 2017 Oct-Dec 2016 Jul-Sep 2016 Apr-Jun 2016 Jan-Mar 2016 Oct-Dec 2015
announcement
Conference/Earnings Calls Alerts
logo
Dalmia Bharat Ltd.
18 Nov 2022
2409.90
-1.56%
Dalmia Bharat Ltd - 542216 - Announcement under Regulation 30 (LODR)-Investor Presentation
BSE India
In reference to above-mentioned subject, we have filed investor presentation as per Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 for November 2022 vide letter dated November 10, 2022. In this connection, please find the enclosed revised Investor Presentation - November 2022, which is proposed to be shared with Analysts / Investors.
pdf
logo
Shreeji Translogistics Ltd.
18 Nov 2022
12.47
-2.20%
pdf
T
Tips Films Ltd.
18 Nov 2022
457.45
0.22%
pdf
T
Tips Films Ltd.
18 Nov 2022
457.45
0.22%
pdf
logo
Hindustan Unilever Ltd.
18 Nov 2022
2559.60
-1.05%
pdf
logo
Hindustan Unilever Ltd.
18 Nov 2022
2559.60
-1.05%
pdf
logo
Cera Sanitaryware Ltd.
18 Nov 2022
6264.00
-1.32%
pdf
logo
DCW Ltd.
17 Nov 2022
74.26
-0.30%
pdf
logo
Agarwal Industrial Corporation Ltd.
17 Nov 2022
989.15
1.96%
AGARWAL INDUSTRIAL CORPORATION LTD. - 531921 - Announcement under Regulation 30 (LODR)-Investor Presentation
BSE India
Dear Sir/Madam, Sub: Investor Presentation for the quarter and half year ended September 30, 2022 In compliance with the provisions of Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith Investor Presentation on Un-audited Financial Results for the Quarter and Half Year ended September 30, 2022. Kindly take the same on your record.
pdf
logo
Alivus Life Sciences Ltd.
17 Nov 2022
1047.45
10.62%
pdf